Navigation Links
Alfacell Provides Shareholder Update
Date:6/19/2009

r, I am totally committed to our future success. I believe we have a unique opportunity to make a noticeable impact in the field of oncology giving those patients debilitated by these dreadful cancers the opportunity to live meaningful lives while we continue to find better therapies and one day a permanent cure for cancer.

Sincerely,

Charles Muniz

President, Chief Operating Officer

About ONCONASE(R)

ONCONASE is a first-in-class therapeutic product candidate based on Alfacell's proprietary ribonuclease (RNase) technology. A natural protein isolated from the leopard frog, ONCONASE has been shown in the laboratory and clinic to target cancer cells while sparing normal cells. ONCONASE triggers apoptosis, the natural death of cells, via multiple molecular mechanisms of action.

About Alfacell Corporation

Alfacell Corporation is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials. The product candidate, ONCONASE, is an RNase that overcomes the challenges of targeting RNA for therapeutic purposes while enabling the development of a new class of targeted therapies for cancer and other life-threatening diseases. For more information, visit www.alfacell.com.

Safe Harbor

This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe," "estimate," "project," "expect" or similar expressions. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, uncertainty whether the clinical trial results will
'/>"/>

SOURCE Alfacell Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Alfacell Provides ONCONASE(R) NDA Submission Update
2. Paper in Molecular Cancer Therapeutics Reports that a Novel Combination of Alfacells ONCONASE(R) and Rosiglitazone Induces a Synergistic Apoptotic Effect in Several Cancer Cell Lines
3. Alfacell Announces ONCONASE(R) Distribution and Marketing Agreement with Megapharm for Israel
4. Alfacell Corporation Announces Preliminary Results From ONCONASE(R) Phase IIIb Clinical Trial
5. Alfacells ONCONASE(R) Shows Potential as Radiation Sensitizer for Lung Cancer Treatment
6. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
7. Alfacell Reports Financial Results for First Quarter of Fiscal 2008
8. Alfacell Corporation to Present at UBS Global Life Sciences Conference
9. Alfacell Updates Status of ONCONASE(R) Phase III Clinical Program
10. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
11. Cephalon Provides Clinical Update on Lestaurtinib in Relapsed Acute Myelogenous Leukemia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... LUBBOCK, Texas , Sept. 19, 2014 Kiromic, ... today the addition of Kent Hance , the former ... vice chairman. Hance retired as chancellor in July 2014, after ... pleased to announce that Kent Hance , the most ... joined the Kiromic team not only as an investor, but ...
(Date:9/19/2014)... RESEARCH TRIANGLE PARK, N.C. , Sept. 19, ... company focused on cloud-based drug design and development, ... strategy. The company,s mission is to design new ... Phase 1 and 2 partners to further their ... enhance its portfolio investments. To support this business ...
(Date:9/19/2014)... , Sept. 19, 2014 Merck (NYSE: MRK ... and Canada , is teaming with celebrity ... Diabetes: Logra Tus Metas , an educational program encouraging Hispanics with ... -- a key treatment goal to help reduce the risk of ... are at a higher risk for developing type 2 diabetes ...
Breaking Medicine Technology:Former Texas Tech Chancellor Named New Vice Chairman of the Board of Kiromic, LLC 2Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5
... chain, has revealed that one in four* (24%) of the population ... or applied medicines which they later discovered were out of date. ... people do not always check the expiry date of medicines before ... This is worrying considering that nearly one in six people ...
... A major new study presented today at the yearly ... in New Orleans shows conclusively that replacing defective aortic ... than through much more invasive open-heart surgery – leads ... trial study ( PARTNER cohort A: Transcatheter valves noninferior ...
Cached Medicine Technology:Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 2Lloydspharmacy Reveals Over 11 Million Britons Risking Health by Taking Old Medicines 3Major New Study Shows Aortic Valve Replacement Via Catheter Produces Better Outcomes Than Traditional Open-Heart Surgery 2Major New Study Shows Aortic Valve Replacement Via Catheter Produces Better Outcomes Than Traditional Open-Heart Surgery 3
(Date:9/20/2014)... (PRWEB) September 20, 2014 Final Cut ... announced the release of the Information theme for FCPX filmmakers. ... use to describe the Information theme,” says Christina Austin, CEO ... to look so professional.” , Information features easy to use ... parameters of the environment. Change the background color, color of ...
(Date:9/20/2014)... MarijuanaDoctors.com recently returned to New ... PAIN Week conference that was held at the ... Las Vegas from September 2nd to September 6th. ... in the hopes of educating physicians in regards ... tool to treat chronic Pain, MarijuanaDoctors.com accomplished goals ...
(Date:9/19/2014)... 19, 2014 “Copay coupons,” a drug ... brand drugs among patients with prescription drug coverage, may ... a new report from the Department of Health ... Federal anti-kickback laws prohibit suppliers from offering side-payments to ... federal government. , The report highlights that two recent ...
(Date:9/19/2014)... 2014 (HealthDay News) -- As kids transition from elementary ... cyberbullies, according to a recent study. But ... 8 found that verbal and physical bullying declines as ... intervention and prevention strategies must address all types of ... and girls, the researchers said. The study was published ...
(Date:9/19/2014)... with The Melanoma Genetics Consortium, GenoMEL, an international research ... Journal of the National Cancer Institute that proves ... the first time, we have established that the genes ... in the risk of developing melanoma," said lead author ... at the University of Leeds (UK). , Telomeres ...
Breaking Medicine News(10 mins):Health News:Today Pixel Film Studios Announced the Release of the Information Theme for Final Cut Pro X 2Health News:MarijuanaDoctors.com Experiences Unprecedented Support and Growth at Pain Week 2014 2Health News:PCMA: New OIG Report Cites Drug Manufacturer“Copay Coupon” Use in Medicare Part D 2Health News: Cyberbullying Seems to Ramp Up in Middle School 2Health News:Melanoma risk found to have genetic determinant 2
... Customers to Contribute $5 to Support,the American Red ... The Wireless Foundation,and the American Red Cross ... can make a charitable donation to the Red ... program. Here,s how it works:,Subscribers of participating wireless ...
... launch a new series in the ... field of cancer research., ... exclusive XM Satellite broadcast to health care,professionals of Stand Up To ... ReachMD XM 157 joins the,major TV networks of ABC, CBS and ...
... Entertainment to State,s Largest Hospice ... ... LodgeNet,Healthcare, a division of LodgeNet Interactive Corporation (Nasdaq: LNET ),today ... Patient Television System to the state,s first,hospice program, St. Francis Hospice ...
... reluctance to prescribe antidepressants, study suggests , , TUESDAY, Sept. 2 ... on the rise after a 15-year decline, and the trend ... a new study suggests. , Researchers thought a spike in ... the new study found the increase in suicides continued during ...
... Chapel Hill researchers have demonstrated that a drug called ... and hospital admissions in children with acute gastroenteritis. , ... that causes vomiting and diarrhea. It is often popularly ... in children during the winter months. , "Children under ...
... says , , TUESDAY, Sept. 2 (HealthDay News) -- ... and cancer risk, but it also suggests that ... The results of a small study published recently ... of developing cancer. In that study, called SEAS, ...
Cached Medicine News:Health News:Wireless Subscribers Can Text 2HELP the American Red Cross 2Health News:Wireless Subscribers Can Text 2HELP the American Red Cross 3Health News:ReachMD XM 157 to Present Stand Up To Cancer Special as the Only Live Simulcast on XM Satellite Radio for Health Care Professionals 2Health News:ReachMD XM 157 to Present Stand Up To Cancer Special as the Only Live Simulcast on XM Satellite Radio for Health Care Professionals 3Health News:LodgeNet Healthcare Expands Into Hawaii Through Agreement With St. Francis Hospice 2Health News:LodgeNet Healthcare Expands Into Hawaii Through Agreement With St. Francis Hospice 3Health News:Youth Suicides Continue to Rise in U.S. 2Health News:Youth Suicides Continue to Rise in U.S. 3Health News:Ondansetron reduces vomiting, hospital admissions in children with gastroenteritis 2Health News:No Definitive Link Seen Between Vytorin and Cancer 2Health News:No Definitive Link Seen Between Vytorin and Cancer 3
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: